Breast Implants Market Size, Share & Trends Analysis Report By Type (Silicone Implants, Form-stable Implants, Saline Implants, Structured Saline Implants), By Applications (Reconstructive Surgery, Cosmetic Surgery), By End-User (Hospital, Cosmetology Clinic, Others), By Shape (Round, Anatomical), By Texture (Smooth, Textured) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The global breast implants market size was valued at USD 1,783.58 million in 2022. It is estimated to reach USD 3,396.71 million by 2031, growing at a CAGR of 7.42% during the forecast period (2023–2031).

A breast implant is a prosthesis utilized to alter a person's breast size, shape, and contour. Breast implants can be inserted during reconstructive plastic surgery to restore a natural-looking breast after a mastectomy, to treat congenital chest wall abnormalities and malformations, or to enhance the breast's appearance cosmetically through breast augmentation surgery. Four kinds of breast implants are distinguished by their filler material: saline solution, silicone gel, structured, and composite filler.

Anesthesia, incision, insertion, positioning, and closure of the devices with multilayer sutures or surgical tape in the breast tissue are all steps in a breast implant procedure. The tissue expander device creates and builds an implant pocket for a subsequent permanent breast implant during surgical therapy for breast reconstruction. The breast prosthesis known as a pectoral implant addresses anomalies and malformations of the male breast and reconstructs the male chest wall.

Highlights

• Silicone implants dominate the type segment
• Cosmetic surgery dominates the application segment
• Hospital dominates the end-user segment
• North America is the highest shareholder in the global market

Market Dynamics

Global breast implants market drivers

Rising incidence of breast cancer

The global prevalence of breast cancer has considerably increased in recent years, fueling the desire for better and more precise treatment methods. According to the World Health Organization's March 2021 report, 685,000 women died from breast cancer in 2020, with an anticipated 2.3 million new cases. In addition, breast cancer is among the most common types of cancer, and 7.8 million women still alive have been diagnosed in the last five years. As a result, the market is anticipated to expand.

Furthermore, breast cancer was the most common type of cancer worldwide in 2020, according to the Global Cancer Observatory's (Globocan) report, with 2,261,419 new cases being diagnosed. According to the same source, breast cancer cases are anticipated to rise from 2,261,419 instances in 2020 to 3,025,471 new cases by 2040. According to these statistics, the incidence of breast cancer is rising globally, which is anticipated to fuel the market for breast implants.

Increasing number of breast augmentation procedures

Breast augmentation, also known as augmentation mammoplasty, has been experiencing a significant rise in popularity and occurrence worldwide. Reconstructive breast surgery can be done as a part of the treatment for breast cancer, whereas cosmetic breast surgery is done for aesthetic purposes. According to the 2020 report of the American Society and Plastics Surgeon, breast augmentation is one of the top five cosmetic surgeries performed in the United States in 2020. The total number of breast augmentation procedures reached 193,073 in 2020. Therefore, the rising breast augmentation procedures are expected to enhance the market's growth during the forecast period.

Global breast implants market restraints

Post complications and risks associated with breast implants

Over recent years, reports of complications among women with implants have been published in several medical journals and extensively discussed at public FDA meetings. Implant complications, like capsular contracture, additional surgeries, breast pain and alteration in nipple and breast sensation, scar tissue that appears around the implant and squeezes it, rupture and deflation, and breast implant associated-anaplastic hyperplasia are some of the complications and adverse outcomes of breast implants, according to the official statement released by the United States Food and Drug Administration (FDA). Hence, such risks associated with breast implants may hinder market growth.

Global breast implants market opportunities

Technological advancement

With the newest implant options and surgical techniques, breast augmentation has become much better. It can help women get a natural look while improving their confidence and body image. According to the article published in the Advances in Medical and Surgical Engineering in 2020, surgical tools and techniques are also advancing as implant technology improves. In addition, one of the most impactful developments in breast augmentation was the introduction of the Keller Funnel. The Keller Funnel resembles the piping bag a pastry chef uses to frost a cake. The Keller Funnel can lessen stress on the implant and the patient's body when introducing a breast implant.

Earlier, women seeking breast implants were required to choose between the safety of saline or the more realisticness of silicone gel. For instance, IDEAL IMPLANT Structured Breast Implant is one next-generation technology that offers women the benefits of feeling beautiful and secure. It has a series of implant shells nested together and two separate chambers holding the saline. All these factors are likely to create opportunities for growth in the market.

Regional Analysis

Based on region, the global breast implants market is bifurcated into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.

North america dominates the global market

North America is the most significant global breast implants market shareholder and is anticipated to exhibit a CAGR of 7.52% during the forecast period. This is mostly a result of the strong demand for breast augmentation procedures brought on by several local entertainment sectors and women's increased self-awareness. The United States is predicted to dominate the market for breast implants in North America over the forecast period. One of the key drivers of market expansion in the United States is the increased demand among women for cosmetic operations and procedures. For instance, breast augmentation was one of the top five cosmetic surgery treatments in the United States in 2020, according to a study from the American Society of Plastic Surgeons. In addition, the increase in product approvals by different regulatory bodies is anticipated to aid in the market's expansion. As an illustration, Mentor Worldwide LLC got approval from the US Food and Drug Administration in January 2022 for its MENTOR Memory Gel BOOST breast implant.

Europe is estimated to exhibit a CAGR of 7.20% over the forecast period. Germany is the largest revenue contributor in the region. The breast implants market in the country is growing due to the increasing breast augmentation procedures and product launches. According to the 2019 International Society of Aesthetic Plastic Surgery survey, 66,972 breast augmentation procedures were performed in 2019 compared to 65,876 procedures in 2018. In addition, POLYTECH Health and Aesthetics GmbH are constantly developing new processes to meet the high-quality standards and current requirements for medical devices. In November 2019, Evonik, a global leader in biomaterials for implantable medical devices, and BellaSeno GmbH, a German developer of 3D-printed absorbable scaffolds, announced the signing of a long-term agreement for the use of a RESOMER bioresorbable polymer for an innovative breast implant technology. Such collaborations drive market growth.

In Asia-Pacific, the growing burden of breast cancers and the increasing awareness of cosmetic and reconstructive procedures drive market growth. For instance, according to Globocan 2020, Breast cancer was topmost cancer diagnosed in India in 2020, with nearly 178,361 new breast cancer cases and nearly 90,408 deaths due to breast cancer in India. Hence, the country's high incidence of breast cancer is expected to drive the market-studied growth. Furthermore, the growing research activities, approval, and launch of new products by key regional players drive market growth. For instance, Allergan started a clinical study in April 2020 to assess the safety of McGhan single-lumen gel-filled breast implants in Chinese patients. Similarly, in August 2020, Sientra Inc. received approval from Japan's Pharmaceutical and Medical Device Agency (PDMA) to commercialize the company's entire OPUS line of breast implants in Japan. Consequently, owing to the factors above, the market is anticipated to experience healthy growth during the forecast period.

The Middle East and African market is further sub-segmented into GCC, South Africa, and the Rest of MEA. The GCC countries include Bahrain, Oman, Kuwait, Qatar, United Arab Emirates, and Saudi Arabia. Cosmetic surgery is gaining popularity among the people in Saudi Arabia. Increasing demand for "nip and tucks" contributes to a lucrative cosmetics market in the Middle East. In addition, Dubai has the highest standards concerning hospitals and private clinics that offer all types of surgery and are suitable for all procedures. Dubai also has the best plastic surgeons. This factor has augmented the growth of the market.

The Latin American market is estimated to grow significantly over the forecast period because Brazil ranks second in breast augmentation in the most popular surgical procedures, followed by the United States. This indicates a high demand for breast implants in this country. This factor is contributing to the current market's growth.

Segmental Analysis

The global breast implants market is segmented by type, application, and end-user.

Based on type, the global market is bifurcated into silicone implants, form-stable implants, saline implants, and structured saline implants. 

The silicone implants segment dominates the global market and is predicted to exhibit a CAGR of 7.09% over the forecast period. The silicone shells of these implants are filled with a plastic gel (silicone). Silicone implants can be inserted through an axillary incision. Since silicone implants are typically thicker, when a silicone gel-filled implant ruptures, the gel may remain in the shell or the scar tissue around the implant. As a result, the person may notice a decrease in breast size, hard lumps over the implant or chest area, a change in the shape of the implant, an uneven appearance of the breasts, and they may even experience pain, tingling, or swelling. Breast augmentation for women over 22 and breast reconstruction for women of any age are permitted for silicone gel-filled breast implants.

Form-stable implants, also known as gummy bear breast implants, stay their shape even if the implant shell is fractured. Furthermore, the silicone gel's consistency inside such implant is thicker than traditional silicone gel implants. Form-stable implants are only permitted in adults over 22 or women of any age who undergo breast reconstruction following cancer. Furthermore, form stable implants require slightly longer incisions in the skin. The major advantage of such implants is that they retain their shape and maintain the natural softness of the breasts.

Based on application, the global market is bifurcated into reconstructive surgery and cosmetic surgery. 

The cosmetic surgery segment is the most significant contributor to the market share and is anticipated to exhibit a CAGR of 7.76% over the forecast period. Reconstructive surgeries repair bodily parts damaged by disease, trauma, infection, tumors, congenital malformations, developmental abnormalities, or developmental abnormalities with an aesthetic or functional impact. After a mastectomy, lumpectomy, or congenital disabilities, the main objective of breast reconstruction surgery is to return one or both breasts to a state relatively close to normal in terms of size, shape, symmetry, and contour. Increased breast cancer cases worldwide are the main cause fueling the market's expansion.

Breast augmentation is a type of cosmetic surgery that typically involves the implantation of saline or silicone breast implants to increase breast size and improve breast shape. Breast augmentation is an outpatient operation performed under a general anesthetic. After a few hours of surgery, the patient can walk independently, and most patients feel well enough to leave the house the next day or two. Nowadays, consumers worldwide are showing an increasing interest in their aesthetic appearance, which is expected to propel the expansion of the market in the next few years.

Based on the end-user, the global market is segmented into hospitals, cosmetology clinics, and others. 

The military and aerospace segment owns the highest market share and is projected to exhibit a CAGR of 736% during the forecast period. Breast implant surgeries can be performed in a hospital or surgery center. In the case of breast implant surgeries, patients may need to spend the night in the hospital, or they may be able to return home immediately. The length of the hospital stay following breast implant surgery depends on the procedure, any postoperative complications, and the patient's overall health. The type of insurance coverage offered may also influence how long the patient stays in the hospital. Furthermore, most patients looking for reconstruction surgeries prefer hospitals rather than clinics. Moreover, the quality of breast implantation depends upon the presence of qualified surgeons and consultants in the hospitals.

Cosmetic surgeries, like breast augmentation and breast lifts, are performed in aesthetic clinics. The segment is expected to develop, owing to patients' increasing interest in their aesthetic appearance. High patient satisfaction has made aesthetic clinics more popular among patients. Due to the surge in aesthetic clinics and the increase in breast implant surgeries, the market is expected to grow.

Recent Developments

1. October 2022- A privately held medical technology company GC Aesthetics' new micro-textured anatomical breast implant LUNA xt received CE approval under the new European Medical Device Regulation (MDR).
2. June 2022- CollPlant announced the start of research for its 3D bioprinted regenerative breast implant program. CollPlant is a regenerative and aesthetic medicine firm creating cutting-edge technology and solutions for tissue regeneration and organ fabrication.